Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.
Moderna said on Friday (May 17) the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech. A sign ...
MODERNA gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
Covid-19 mRNA vaccines may have contributed to the 3.1 million excess deaths – that is, the number of deaths beyond what ...
SINGAPORE – Covid-19 mRNA vaccines may have contributed to the 3.1 million excess deaths – that is, the number of deaths ...
Advisers to the US Food and Drug Administration on Wednesday (Jun 5) unanimously voted in favour of recommending that ...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
First mRNA vaccine approved for a disease other than COVID Moderna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking ...